HydroxycarbamideLack of efficacy: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1853卷 / 1期

关键词：

D O I：

10.1007/s40278-021-95094-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：228 / 228

相关论文

共 50 条

[41] AtropineLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1960 (1) : 79 - 79
[42] VismodegibLack of efficacy: 5 case reports
Reactions Weekly, 2022, 1920 (1) : 454 - 454
[43] AntineoplasticsLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1948 (1) : 56 - 56
[44] NivolumabLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1963 (1) : 426 - 426
[45] MultipleLack of efficacy: 5 case reports
Reactions Weekly, 2022, 1915 (1) : 279 - 279
[46] CefazolinLack of efficacy: 5 case reports
Reactions Weekly, 2024, 2035 (1) : 138 - 138
[47] AntineoplasticsLack of efficacy: 5 case reports
Reactions Weekly, 2020, 1817 (1) : 44 - 44
[48] AntineoplasticsLack of efficacy : 5 case reports
Reactions Weekly, 2022, 1908 (1) : 67 - 67
[49] PentobarbitalLack of efficacy: 5 case reports
Reactions Weekly, 2024, 2036 (1) : 391 - 391
[50] OsimertinibLack of efficacy: 5 case reports
Reactions Weekly, 2022, 1934 (1) : 356 - 356

← 1 2 3 4 5 →